Valuation: Center Laboratories, Inc.

Market Cap 29.6B 926M 810M 744M 694M 1.32B 88.19B 1.34B 8.93B 3.47B 43.35B 3.48B 3.4B 149B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 33.64B 1.05B 920M 846M 788M 1.5B 100B 1.52B 10.15B 3.95B 49.27B 3.95B 3.87B 170B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day+3.26%
1 week+6.59%
Current month+3.93%
1 month+3.12%
3 months-4.92%
6 months-2.10%
Current year-4.69%
1 week 37.5
Extreme 37.5
40.25
1 month 36.8
Extreme 36.8
40.25
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 03/08/1998
Director of Finance/CFO - 08/12/2022
Chief Tech/Sci/R&D Officer - 01/07/1983
Director TitleAgeSince
Chairman - 30/11/2022
Director/Board Member 61 14/06/2010
Director/Board Member - 14/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
+3.26%+6.59%+13.05%-16.29% 926M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+31.35%+24.29% 338B
-0.56%+0.96%+39.86%+36.64% 299B
-0.08%+1.30%+30.37%+44.02% 291B
-1.54%+2.81%-27.56%-39.45% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +2.21%+4.54%+29.20%+50.41% 369.33B
Weighted average by Cap. +2.25%+5.53%+41.77%+82.98%

Financials

2024 2025
Net sales 1.62B 50.62M 44.25M 40.67M 37.91M 71.9M 4.82B 72.99M 488M 190M 2.37B 190M 186M 8.16B 1.52B 47.44M 41.47M 38.11M 35.53M 67.38M 4.52B 68.41M 458M 178M 2.22B 178M 174M 7.65B
Net income -1.1B -34.53M -30.19M -27.74M -25.86M -49.05M -3.29B -49.8M -333M -129M -1.62B -130M -127M -5.57B 9.32B 292M 255M 234M 218M 414M 27.78B 421M 2.81B 1.09B 13.65B 1.09B 1.07B 47.05B
Net Debt 4.48B 140M 123M 113M 105M 199M 13.35B 202M 1.35B 526M 6.56B 526M 515M 22.61B 4.04B 126M 111M 102M 94.7M 180M 12.04B 182M 1.22B 474M 5.92B 475M 464M 20.39B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
03/07/26 NT$39.65 +3.26% 8,219,167
02/07/26 NT$38.40 +0.79% 3,044,141
01/07/26 NT$38.10 -0.13% 1,346,883
30/06/26 NT$38.15 +0.26% 1,735,048
29/06/26 NT$38.05 +2.28% 1,890,029
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. 4123 Stock